Decision

UK REACH authorisation for Ortho-Clinical Diagnostics, 26 July 2021

Decision on application for authorisation under UK REACH.

• From: Department for Environment, Food & Rural Affairs
• Published: 3 August 2021

Applies to England, Scotland and Wales

Documents

Ortho-Clinical Diagnostics: authorisation granted UKREACH/21/01/0

PDF, 121 KB, 6 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Decision on a transitional application for authorisation under UK REACH.

Substance name

4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated.

Authorised use

Formulation of 4-(1,1,3,3-Tetramethylbutyl) phenol, ethoxylated (as Triton X-100) for use in the manufacture of in vitro diagnostic VITROS® products used for infectious disease screening, endocrinology, and oncology testing.

Holder of the authorisation and authorisation number

Ortho-Clinical Diagnostics (UKREACH/21/01/0) .

Date of decision

26 July 2021

Published 3 August 2021